Literature DB >> 22663985

Expression of transient receptor potential melastatin 7 up-regulated in the early stage of renal ischemia-reperfusion.

Z Meng1, X Wang, Z Yang, F Xiang.   

Abstract

BACKGROUND: Transient receptor potential melastatin 7 (TRPM7), a bifunctional protein with kinase and ion channel activities, was first reported in 2001. Later studies suggested that the functions of TRPM7 related to cancer, ischemic injury, and hypertension.
METHODS: We examined whether TRPM7 expression changed in renal ischemia-reperfusion injury (RIRI). Seventy male Sprague-Dawley rats weighing 220-250 g were randomly divided into 7 groups of 7 rats each; every group had a sham-operated cohort of 3 rats. After the right kidney was removed, the rats underwent 45 minutes of left renal artery occlusion followed by reperfusion for 1, 12, 24, 48, 72, or 96 hours. There after the expression of TRPM7 messenger RNA (mRNA) was measured using real-time polymerase chain reaction (RT-PCR) and the protein using Western blot.
RESULTS: Compared with the control group, the expression of TRPM7 mRNA was significantly up-regulated at 24 hours after ischemia-reperfusion. We set the expression of TRPM7 mRNA of the control group as the baseline (1.0), with the 1-hour, 12-hour, 24-hour, 48-hour, 72-hour and 96-hours showing 2.83, 3.16, 3.95, 0.31, 0.82, and 1.13, respectively (n = 7; P < .05). TRPM7 protein expression showed the same trends as the mRNA. The main change in TRPM7 protein was located in tubular cells.
CONCLUSIONS: The expressions of TRPM7 mRNA and protein levels was up-regulated at 24 hours after renal ischemia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22663985     DOI: 10.1016/j.transproceed.2011.11.068

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Evaluation of TRPM (transient receptor potential melastatin) genes expressions in myocardial ischemia and reperfusion.

Authors:  Tuncer Demir; Onder Yumrutas; Beyhan Cengiz; Seniz Demiryurek; Hatice Unverdi; Davut Sinan Kaplan; Recep Bayraktar; Nadide Ozkul; Cahit Bagcı
Journal:  Mol Biol Rep       Date:  2014-01-21       Impact factor: 2.316

2.  Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation.

Authors:  Zhe Meng; Rui Cao; Yongzhi Wang; Hong Cao; Tao Liu; Zhonghua Yang; Xinghuan Wang
Journal:  World J Urol       Date:  2013-11-21       Impact factor: 4.226

Review 3.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

4.  Renal ischemia-reperfusion injury impairs renal calcium, magnesium, and phosphate handling in mice.

Authors:  Manuel Meurer; Klaus Höcherl
Journal:  Pflugers Arch       Date:  2019-01-26       Impact factor: 3.657

5.  Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.

Authors:  Tayze T Antunes; Glaucia E Callera; Ying He; Alvaro Yogi; Alexey G Ryazanov; Lillia V Ryazanova; Alexander Zhai; Duncan J Stewart; Alvin Shrier; Rhian M Touyz
Journal:  Hypertension       Date:  2016-02-29       Impact factor: 10.190

6.  Differential mRNA expression and glucocorticoid-mediated regulation of TRPM6 and TRPM7 in the heart and kidney throughout murine pregnancy and development.

Authors:  James S M Cuffe; Sarah Steane; Karen M Moritz; Tamara M Paravicini
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury.

Authors:  Aifen Liu; Jing Wu; Cheng Yang; Yuanyuan Wu; Yufang Zhang; Fengbo Zhao; Hui Wang; Li Yuan; Lirui Song; Tongyu Zhu; Yaping Fan; Bin Yang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.